Spectrum Pharmaceuticals

Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Law firms target Spectrum over lung cancer trial statements
Fierce Biotech
Tue, 01/24/23 - 10:20 am
Spectrum Pharmaceuticals
legal
class action lawsuits
clinical trials
poziotinib
Black Friday for Spectrum as FDA lung cancer rejection prompts 75% cut to R&D workforce
Fierce Biotech
Mon, 11/28/22 - 10:40 am
Spectrum Pharmaceuticals
layoffs
R&D
FDA
Pozenveo
FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
BioSpace
Mon, 11/21/22 - 10:06 am
FDA
Spectrum Pharmaceuticals
poziotinib
Immunogen
mirevtuximab soravtansine
Scynexis
Brexafemme
Y-mAbs
Omblastys
FDA advisory committee issues back to back negative votes on two cancer drugs
MedCity News
Mon, 09/26/22 - 10:31 am
FDA
Spectrum Pharmaceuticals
Oncopeptides
clinical trials
poziotinib
Pepaxto
Multiple Myeloma
FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting
Endpoints
Tue, 09/20/22 - 08:40 pm
FDA
oncology
Spectrum Pharmaceuticals
Oncopeptides
poziotinib
Pepaxto
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
Spec­trum hits the re­set but­ton, slic­ing away 30% of its work­force in piv­ot around 2 lead as­sets
Endpoints
Wed, 01/5/22 - 10:30 pm
Spectrum Pharmaceuticals
COVID-19
layoffs
restructuring
ESMO 2021 – Mirati bids to be belle of the ball
EP Vantage
Tue, 09/14/21 - 10:41 am
ESMO
Mirati Therapeutics
Faron Pharmaceuticals
Amgen
Spectrum Pharmaceuticals
FDA shoots down Spectrum's neutropenia drug, citing manufacturing issues
Endpoints
Fri, 08/6/21 - 11:06 am
Spectrum Pharmaceuticals
FDA
neutropenia
cancer
Rolontis
Spectrum's Rolontis hits another setback as FDA faces COVID-19 plant inspection backlog
Fierce Pharma
Tue, 10/27/20 - 11:55 am
Spectrum Pharmaceuticals
neutropenia
Rolontis
drug launches
pandemic
COVID-19
A turn-up for Spectrum’s book
EP Vantage
Tue, 07/28/20 - 10:32 am
poziotinib
Spectrum Pharmaceuticals
lung cancer
Takeda
Clinical developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:35 pm
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Spectrum bags cancer drugs, interferon platform from ImmunGene
Fierce Biotech
Thu, 05/9/19 - 10:46 am
Spectrum Pharmaceuticals
ImmunGene
drug development
interferon
Spectrum yanks marketing application for Neulasta rival after FDA demands more data
Endpoints
Fri, 03/15/19 - 11:04 am
Spectrum Pharmaceuticals
FDA
lung cancer
poziotinib
Neulasta
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
CP Wire
Fri, 06/29/18 - 10:07 am
Spectrum Pharmaceuticals
Rolontis
neutropenia
Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia
Fri, 06/29/18 - 10:00 am
Spectrum Pharmaceuticals
Spectrum Pharma Is Weighing a Sale
Bloomberg
Wed, 06/27/18 - 11:39 am
Spectrum Pharmaceuticals
M&A
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
3 Biotech Stocks to Be Thankful for This Year
Yahoo/Motley Fool
Mon, 11/20/17 - 09:30 am
biotech
Loxo Oncology
Nektar
Spectrum Pharmaceuticals

Pages